Neuronetics Stock Statistic Functions Beta
| STIM Stock | USD 1.30 0.03 2.36% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Neuronetics correlated with the market. If Beta is less than 0 Neuronetics generally moves in the opposite direction as compared to the market. If Neuronetics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Neuronetics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Neuronetics is generally in the same direction as the market. If Beta > 1 Neuronetics moves generally in the same direction as, but more than the movement of the benchmark.
Neuronetics Technical Analysis Modules
Most technical analysis of Neuronetics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neuronetics from various momentum indicators to cycle indicators. When you analyze Neuronetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
Neuronetics is scheduled to announce its earnings this week.Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Neuronetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 198 people. Liquidity and trading activity can influence how quickly new information is reflected in Neuronetics's price. Lower trading activity may introduce occasional variability in execution conditions. Neuronetics has a market cap of 86.98 M, ROE of -2.19%.
Methodology
Unless otherwise specified, financial data for Neuronetics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Neuronetics (USA Stocks:STIM) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Neuronetics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of DirectorsSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neuronetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neuronetics' short interest history, or implied volatility extrapolated from Neuronetics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Software Invested few shares | |
 | Investor Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Momentum Invested few shares | |
 | Advertising Invested few shares | |
 | Video Games Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Impulse Invested over 200 shares | |
 | ESG Investing Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
More Resources for Neuronetics Stock Analysis
Understanding Neuronetics typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Neuronetics Stock. Outlined below are key reports that provide context for Neuronetics Stock:Neuronetics has a market cap of 86.98 M, operating margin of -19.63%, ROE of -2.19%. Review World Market Map for broader portfolio context. This reflects a position in Neuronetics within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. New to investing in Neuronetics Stock? Start with our How to Invest in Neuronetics Stock guide for a step-by-step overview.Analysis related to Neuronetics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Earnings Share -0.83 | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price can diverge from book value, the accounting figure shown on Neuronetics's balance sheet. Neuronetics' market capitalization is 86.98 M. With a P/B ratio of 3.23, the market values Neuronetics well above its book equity. Enterprise value stands at 150.95 M. Intrinsic value reflects what Neuronetics' fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Neuronetics' value from its trading price, which are computed with different methods. For Neuronetics, key inputs include a P/B ratio of 3.23, a profit margin of -34.27%, ROE of -2.19%, and revenue of 74.89 M. The quoted price is simply the exchange level where supply meets demand.